291
Olema Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
209
FY23:
267
FY24:
438
FY25:
515
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.26
FY22:
6.75
FY23:
10.4
FY24:
12.5
FY25:
18.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
296
FY22:
216
FY23:
277
FY24:
451
FY25:
533
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.02
FY22:
16.5
FY23:
21.6
FY24:
41.8
FY25:
51.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.36
FY22:
1.55
FY23:
1.43
FY24:
0.26
FY25:
3.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
285
FY22:
198
FY23:
254
FY24:
409
FY25:
479
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
296
FY22:
216
FY23:
277
FY24:
451
FY25:
533
All amounts in millions USD